Core Viewpoint - The legal opinion letter issued by Haiwen Law Firm confirms that Jiangsu Chengxing Phosphate Chemical Co., Ltd. has obtained the necessary approvals and authorizations for its 2025 restricted stock incentive plan adjustments and initial grants, in compliance with relevant laws and regulations [4][11][14] Group 1: Legal Compliance and Procedures - The law firm conducted due diligence and verified documents related to the company's 2025 restricted stock incentive plan, ensuring compliance with the Company Law, Securities Law, and Management Measures [3][4] - The company has followed the required legal procedures, including meetings of the remuneration and assessment committee, board of directors, supervisory board, and shareholders' meeting to approve the incentive plan [5][9][10] Group 2: Adjustments to the Incentive Plan - The initial list of incentive recipients was adjusted from 86 to 79 individuals, and the number of restricted stocks granted was reduced from 16 million shares to 14.24 million shares, with the total number of restricted stocks in the plan adjusted from 20 million to 18.24 million shares [10][11] Group 3: Granting Conditions and Details - The granting conditions for the restricted stocks include compliance with financial reporting standards and absence of disqualifying factors as outlined in the Management Measures and the incentive plan [12][14] - The initial grant date for the incentive plan is set for August 15, 2025, with a grant price of 3.21 yuan per share for the 1.424 million shares allocated to the 79 recipients [13][14]

Core Viewpoint - The company conducted a self-examination regarding insider trading related to its 2025 Restricted Stock Incentive Plan, confirming that no insider trading occurred during the specified period [1][2][3] Group 1: Insider Trading Examination - The company held meetings on July 29, 2025, to approve the draft of the 2025 Restricted Stock Incentive Plan and publicly disclosed it on July 31, 2025 [1] - The examination covered the period from January 30, 2025, to July 30, 2025, focusing on insider trading activities by individuals aware of the plan [2] - All individuals subject to the examination did not engage in any trading of the company's stock during the self-examination period [2][3] Group 2: Confidentiality Measures - The company implemented necessary confidentiality measures and registered all insider information holders involved in the planning of the incentive plan [2] - The company maintained strict control over insider information, ensuring that only registered individuals had access to it, and no information leaks were reported prior to the public disclosure [3] - The company confirmed that there were no incidents of insider trading or information leakage related to the incentive plan during the examination period [3]

Core Viewpoint - Jiangsu Chengxing Phosphate Chemical Co., Ltd. has announced the first grant of restricted stock under its 2025 Restricted Stock Incentive Plan, with a total of 14.24 million shares granted to 79 individuals at a price of 3.21 yuan per share, effective from August 15, 2025 [1][5][11]. Group 1: Incentive Plan Details - The first grant date is set for August 15, 2025, with a total of 14.24 million shares to be granted [1][5]. - The number of individuals receiving the grant is 79, with a grant price of 3.21 yuan per share [1][5]. - The plan includes a vesting schedule where the restricted stocks will have a lock-up period of 12, 24, and 36 months, with specific percentages of shares becoming available for sale after each period [6][7]. Group 2: Compliance and Approval Process - The board of directors and the supervisory board have confirmed that all necessary procedures and disclosures have been completed for the incentive plan [2][3]. - The supervisory board has verified the eligibility of the incentive recipients, ensuring compliance with relevant regulations [10][12]. - The plan has been approved by the third extraordinary general meeting of shareholders in 2025, and adjustments to the recipient list were made due to voluntary withdrawals by 7 individuals [9][15]. Group 3: Financial Impact and Valuation - The fair value of the restricted stocks will be determined based on the market value on the grant date, considering the impact of lock-up clauses [13][14]. - The estimated share-based payment expenses will be amortized over the years 2025 to 2028, with a projected impact on net profit, although the overall effect is expected to be minimal [14][15]. - The incentive plan is anticipated to enhance company performance by motivating management and improving operational efficiency [14].

Group 1 - The company has implemented an incentive plan that includes the allocation of restricted stocks to core management, key employees, and high-potential staff, totaling 1,824,000 shares [1] - Of the total shares granted, 1,104,000 shares (60.52%) are allocated to core management and key employees, while 400,000 shares (21.93%) are reserved for future allocation [1] - The total number of shares involved in all effective incentive plans does not exceed 10% of the company's total share capital at the time of the incentive plan announcement [1] Group 2 - The company will disclose relevant information about the incentive recipients after receiving clear opinions from the supervisory board or the compensation and assessment committee, along with legal opinions from lawyers [2] - If the incentive recipients are not clearly defined within 12 months, the reserved rights will become invalid [2]

Core Viewpoint - Suzhou Guangge Technology Co., Ltd. has developed a 2025 Restricted Stock Incentive Plan to attract and retain talent, enhance team cohesion, and align the interests of shareholders, the company, and individuals [1][2]. Group 1: Incentive Plan Overview - The incentive plan aims to establish a long-term incentive mechanism to boost employee motivation and corporate competitiveness [1]. - The plan is designed in accordance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1][2]. Group 2: Assessment Objectives and Principles - The assessment aims to objectively evaluate company performance and the performance of incentive participants, ensuring the successful implementation of the incentive plan [2]. - The assessment adheres to principles of fairness, justice, and transparency, linking the incentive plan closely with the performance and contributions of participants [2][3]. Group 3: Assessment Scope and Participants - The assessment applies to all participants in the 2025 Restricted Stock Incentive Plan, including directors, senior management, and key personnel approved by the board [2][3]. Group 4: Assessment Institutions and Responsibilities - The Human Resources Department is responsible for individual performance assessments, while the Finance Department handles company performance assessments [3]. - The Board's Compensation and Assessment Committee oversees the assessment process and reports the results to the Board [3][6]. Group 5: Assessment Indicators and Standards - The performance assessment for the initial grant of restricted stocks will cover the fiscal years 2025 to 2027, with annual assessments based on revenue growth rates [3][4]. - If performance targets are not met, the corresponding restricted stocks for all participants will not vest or will be deferred [5]. Group 6: Assessment Procedures and Results Management - The assessment results will be communicated to participants, who can appeal if they disagree with the results [6][8]. - The results will be archived as confidential documents for a period of 10 years [6]. Group 7: Additional Provisions - The provisions of the assessment method will be revised as necessary in accordance with changes in laws and regulations [7].

证券代码：688450 证券简称：光格科技 公告编号：2025-050 苏州光格科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ?股权激励方式：限制性股票（第二类限制性股票） ?股份来源：公司向激励对象定向发行公司A股普通股和/或公司从二级市 场回购的公司A股普通股股票。 ?股权激励的权益总数及涉及的标的股票总数：《苏州光格科技股份有限 公司 2025 年限制性股票激励计划（草案）》（以下简称"本激励计划"） 拟向 激励对象授予不超过 75.09 万股的限制性股票，约占本激励计划草案公告时公 司股本总额 6,600.00 万股的 1.14%。其中，首次授予限制性股票 61.72 万股， 占本激励计划草案公告时公司股本总额 6,600.00 万股的 0.94%，首次授予部分 占本次授予权益总额的 82.19%；预留 13.37 万股，占本激励计划草案公告时公 司股本总额 6,600.00 万股的 0.20%，预留部分占本次授予权益总额的 17.81%。 一、股权激励计划目的 为了建立、健全公 ...

乐心医疗 2025 年公告 证券代码：300562 证券简称：乐心医疗 公告编号：2025-086 广东乐心医疗电子股份有限公司 于<2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于<2023 年限制 性股票激励计划实施考核管理办法>的议案》以及《关于提请股东大会授权董事 会办理公司股权激励计划相关事宜的议案》等议案，独立董事就相关事项发表了 一致同意的独立意见。同日，公司召开第四届监事会第七次会议审议通过了《关 于<2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于<2023 年限制 关于作废2023年限制性股票激励计划部分已授予但尚未归属的 第二类限制性股票的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 广东乐心医疗电子股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日 召开的第五届董事会第三次会议，审议通过了《关于作废 2023 年限制性股票激 励计划部分已授予但尚未归属的第二类限制性股票的议案》，现将具体情况公告 如下： 一、本激励计划已履行的决策程序和批准情况 性股票激励计划实施考核管理办法>的议 ...

（一）本次拟归属的第二类限制性股票数量为 38.50 万股，涉及激励对象 30 名； （二）本次拟归属的第二类限制性股票的来源为公司向激励对象定向发行的 公司人民币 A 股普通股股票； 第二个归属期归属条件成就的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 证券代码：300562 证券简称：乐心医疗 公告编号：2025-085 广东乐心医疗电子股份有限公司 关于2023年限制性股票激励计划第二类限制性股票 乐心医疗 2025 年公告 （三）本次拟归属的第二类限制性股票的授予价格为 4.54 元/股（调整后）； （四）本激励计划授予第二类限制性股票的第二个等待期将于 2025 年 8 月 况为其办理相关归属手续，届时公司将根据实际归属结果发布提示性公告，敬请 投资者注意。 广东乐心医疗电子股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日 召开的第五届董事会第三次会议，审议通过了《关于 2023 年限制性股票激励计 划第二类限制性股票第二个归属期归属条件成就的议案》，认为公司 2023 年限 制性股票激励计划（以下简称"本 ...

中远海运能源运输股份有限公司 实施考核管理办法 （修订稿） 二〇二五年【】月 为保证中远海运能源运输股份有限公司（以下简称"公司"）股 权激励计划的顺利进行，进一步完善公司法人治理结构，形成良好均 衡的价值分配体系，持续激励公司中高级管理人员和技术业务骨干关 注公司长远发展并为之共同努力奋斗、助推公司业绩稳步提升，确保 公司发展战略和经营目标的实现，根据《中华人民共和国公司法》等 有关法律、法规及《中远海运能源运输股份有限公司章程》的相关规 定，结合公司内部绩效考核管理制度，制定股票期权激励计划实施考 核管理办法。 一、 考核目的 进一步完善公司法人治理结构，建立和完善公司激励约束机制， 保证股权激励计划的顺利实施，并在最大程度上发挥股权激励的作用， 进而确保公司发展战略和经营目标的实现。 二、 考核原则 考核评价必须坚持公正、公开、公平的原则，严格按照本办法和 考核对象的业绩进行评价，以实现股权激励计划与激励对象工作业绩、 贡献紧密结合，从而提高管理绩效，实现公司与全体股东利益最大化。 三、 考核范围 本办法适用于参与公司本次激励计划的所有激励对象，包括公司 高级管理人员、核心管理人员和业务技术骨干。 四、 ...

Core Viewpoint - The company has announced a change in the purpose of its repurchased shares from maintaining company value and shareholder rights to implementing equity incentives or employee stock ownership plans Group 1: Share Repurchase Plan - The company approved a share repurchase plan using its own funds or borrowed funds, with a maximum repurchase price of 53.24 yuan per share and a total repurchase amount between 40 million yuan and 80 million yuan within three months from the board's approval [1] Group 2: Adjustment of Share Repurchase Purpose - The purpose of the repurchased shares has been adjusted to attract and retain talent, enhancing employee cohesion and company competitiveness, aligning shareholder, company, and core team interests [2][3] - The adjustment does not require shareholder meeting approval and is based on legal regulations and the company's actual situation and development needs [2] Group 3: Impact of the Adjustment - The adjustment aligns with the company's operational status and future development plans, ensuring no significant impact on debt obligations, ongoing operations, or shareholder rights, and does not alter the control structure or listing status [3]